US Patent 8067550 Hybridomas producing antibodies against non functional P2X7 receptor
Patent 8067550 was granted and assigned to Biosceptre International Limited on November, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+148 characters)
Article
Patent abstract
The present invention relates to the production of anti non functional P2X7 receptor monoclonal antibodies from hybridoma cell lines.
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08067550 Hybridomas producing antibodies against non functional P2X7 receptor US Patent 8067550 Hybridomas producing antibodies against non functional P2X7 receptor
Infobox
Patent Number
0806755000
Patent Number
806755000
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080675500
Date of Patent
November 29, 2011
0Patent Application Number
124452730
Date Filed
October 10, 2007
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
080675500
Date of Patent
November 29, 2011
0Patent Application Number
124452730
Date Filed
October 10, 2007
0Patent Primary Examiner
Edits on 14 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08067550 Hybridomas producing antibodies against non functional P2X7 receptor
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08067550
Date of patent
November 29, 2011
Patent application number
12445273
Date Filed
October 10, 2007
Patent primary examiner
Find more entities like US Patent 8067550 Hybridomas producing antibodies against non functional P2X7 receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
